Cargando…
In vivo Imaging With (18)F-FDG- and (18)F-Florbetaben-PET/MRI Detects Pathological Changes in the Brain of the Commonly Used 5XFAD Mouse Model of Alzheimer's Disease
Imaging biomarkers of Alzheimer's disease (AD) that are able to detect molecular changes in vivo and transgenic animal models mimicking AD pathologies are essential for the evaluation of new therapeutic strategies. Positron-emission tomography (PET) using either (18)F-Fluorodeoxyglucose ((18)F-...
Autores principales: | Franke, Timon N., Irwin, Caroline, Bayer, Thomas A., Brenner, Winfried, Beindorff, Nicola, Bouter, Caroline, Bouter, Yvonne |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7522218/ https://www.ncbi.nlm.nih.gov/pubmed/33043029 http://dx.doi.org/10.3389/fmed.2020.00529 |
Ejemplares similares
-
(18)F-FDG-PET Detects Drastic Changes in Brain Metabolism in the Tg4–42 Model of Alzheimer’s Disease
por: Bouter, Caroline, et al.
Publicado: (2019) -
(18)F-FDG-PET in Mouse Models of Alzheimer's Disease
por: Bouter, Caroline, et al.
Publicado: (2019) -
Quantitative Brain Positron Emission Tomography in Female 5XFAD Alzheimer Mice: Pathological Features and Sex-Specific Alterations
por: Bouter, Caroline, et al.
Publicado: (2021) -
Clinical Relevance of [(18)F]Florbetaben and [(18)F]FDG PET/CT Imaging on the Management of Patients with Dementia
por: Librizzi, Damiano, et al.
Publicado: (2021) -
(18)F-florbetaben whole-body PET/MRI for evaluation of systemic amyloid deposition
por: Baratto, Lucia, et al.
Publicado: (2018)